Safety and cardiovascular effects of multiple‐dose administration of aripiprazole and olanzapine in a randomised clinical trial - Koller - 2021 - Human Psychopharmacology: Clinical and Experimental - Wiley Online Library

Synthesis and Characterization of 5-(2-Fluoro-4-[11C]methoxyphenyl)-2,2-dimethyl-3,4-dihydro-2H-pyrano[2,3-b]pyridine-7-carboxamide as a PET Imaging Ligand for Metabotropic Glutamate Receptor 2

PDF) Safety and cardiovascular effects of multiple-dose administration of aripiprazole and olanzapine in a randomised clinical trial

Prevention and treatment of traumatic brain injury-related delirium: a systematic review

A Randomized, Double-Blind, Placebo-Controlled Trial of Aripiprazole Lauroxil in Acute Exacerbation of Schizophrenia

Long-term safety and efficacy of angioplasty of femoropopliteal artery disease with drug-coated balloons from the AcoArt I trial - ScienceDirect

PDF) Important pharmacogenetic information for drugs prescribed during the SARS-CoV-2 infection (COVID-19)

Impact of CYP2C19 Genotype and Drug Interactions on Voriconazole Plasma Concentrations: A Spain Pharmacogenetic‐Pharmacokinetic Prospective Multicenter Study - Blanco‐Dorado - 2020 - Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

A Randomized, Open-Label, Multiple-Dose, Parallel-Arm, Pivotal Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Aripiprazole 2-Month Long-Acting Injectable in Adults With Schizophrenia or Bipolar I Disorder

Schizophrenia and Related Psychoses - Major Reference Works - Wiley Online Library

Pharmacokinetics, tolerability and safety of aripiprazole once-monthly in adult schizophrenia: An open-label, parallel-arm, multiple-dose study

Auditory mismatch responses are differentially sensitive to changes in muscarinic acetylcholine versus dopamine receptor function